CATALOGO DEI PRODOTTI DELLA RICERCA

PIZZOLO, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.810
EU - Europa 9.332
AS - Asia 6.061
SA - Sud America 762
Continente sconosciuto - Info sul continente non disponibili 158
AF - Africa 135
OC - Oceania 19
Totale 27.277
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.631
RU - Federazione Russa 3.408
SG - Singapore 2.503
GB - Regno Unito 2.001
CN - Cina 1.759
DE - Germania 917
IT - Italia 679
BR - Brasile 615
SE - Svezia 580
VN - Vietnam 580
FI - Finlandia 462
FR - Francia 456
HK - Hong Kong 453
IE - Irlanda 394
KR - Corea 206
UA - Ucraina 119
CA - Canada 107
JP - Giappone 87
IN - India 78
TR - Turchia 77
BD - Bangladesh 67
NL - Olanda 66
BE - Belgio 59
AR - Argentina 55
PL - Polonia 43
ZA - Sudafrica 40
MX - Messico 36
ID - Indonesia 34
ES - Italia 30
NG - Nigeria 27
IQ - Iraq 25
CO - Colombia 24
AT - Austria 23
PK - Pakistan 21
UZ - Uzbekistan 18
IR - Iran 17
AU - Australia 16
IL - Israele 15
SA - Arabia Saudita 15
VE - Venezuela 15
CZ - Repubblica Ceca 14
EC - Ecuador 14
CL - Cile 13
JO - Giordania 13
AZ - Azerbaigian 12
EG - Egitto 12
MA - Marocco 12
JM - Giamaica 11
NP - Nepal 11
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
LT - Lituania 9
PY - Paraguay 9
HR - Croazia 8
MY - Malesia 8
PE - Perù 8
AL - Albania 7
LB - Libano 7
PH - Filippine 7
RO - Romania 7
DZ - Algeria 6
EU - Europa 6
HN - Honduras 6
KE - Kenya 6
PT - Portogallo 6
UY - Uruguay 6
LV - Lettonia 5
PS - Palestinian Territory 5
TH - Thailandia 5
CH - Svizzera 4
CR - Costa Rica 4
ET - Etiopia 4
GR - Grecia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
BG - Bulgaria 3
BJ - Benin 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
DK - Danimarca 3
EE - Estonia 3
LU - Lussemburgo 3
MT - Malta 3
NZ - Nuova Zelanda 3
SN - Senegal 3
TG - Togo 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HU - Ungheria 2
ME - Montenegro 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SI - Slovenia 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 27.097
Salva come PNG Salva come JPEG
Città #
Southend 1.627
Singapore 1.411
Moscow 1.162
Ashburn 1.082
Chandler 1.050
Jacksonville 1.029
Dallas 1.000
San Jose 904
Woodbridge 659
Ann Arbor 549
Hong Kong 445
Dublin 392
Verona 350
Council Bluffs 349
Houston 298
New York 294
The Dalles 286
Beijing 261
Ho Chi Minh City 171
Wilmington 170
Los Angeles 166
Lawrence 156
Princeton 156
Munich 138
Helsinki 134
Hanoi 132
Jinan 122
Nanjing 116
Boardman 109
Tokyo 86
Santa Clara 77
Shenyang 77
Buffalo 75
Tianjin 74
Lancaster 72
São Paulo 70
Turku 67
Hebei 60
Nürnberg 60
Brussels 59
Columbus 58
Redondo Beach 57
Sindelfingen 56
Milan 55
Dong Ket 54
Orem 52
Zhengzhou 50
Montreal 46
Nanchang 43
Seoul 43
London 42
Guangzhou 40
Changsha 39
Denver 39
Redmond 38
Seattle 38
Haikou 35
Hangzhou 34
Warsaw 34
Stockholm 33
Ningbo 32
Washington 31
Jiaxing 29
Phoenix 29
Toronto 29
Chicago 28
Frankfurt am Main 28
Boston 26
Chennai 26
Johannesburg 26
Abuja 25
Amsterdam 25
Taiyuan 25
Haiphong 24
Taizhou 24
Brooklyn 23
Poplar 23
Atlanta 22
Da Nang 22
Falkenstein 22
Shanghai 22
Rio de Janeiro 21
San Francisco 21
Padova 19
Manchester 18
Ankara 17
Norwalk 17
Rome 17
Tashkent 17
Jakarta 16
Mestre 16
Vienna 16
Dhaka 14
Düsseldorf 14
Fuzhou 14
Kent 14
Redwood City 14
Lanzhou 13
Boydton 12
Campinas 12
Totale 17.224
Salva come PNG Salva come JPEG
Nome #
Multimodality Imaging in Aldosterone-Induced Cardiomyopathy: Early Detection and Prognostic Implications 388
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 320
Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation 319
Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage 298
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19 262
Abnormal gel flotation caused by contrast media during adrenal vein sampling 260
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 256
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 251
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 244
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 241
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 229
Novel serum paraoxonase activity assays are associated with coronary artery disease 227
Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. 227
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 223
Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test 223
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 220
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 220
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 205
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 205
Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. 203
Acquired and genetic determinants of homocysteine in atheromatous renel artery stenosis with mild renal insufficiency 201
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg 201
miRNAs purification and analysis from urinary exosomes. 200
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 197
ApoC-III gene polymorphisms and risk of coronary artery disease 196
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 196
Aldosterone to renin ratio in a primary care setting:the Bussolengo study. 195
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 194
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 192
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 188
High ferritin and low folate increases PBMCs genomic DNA methylation in association with SHMT1-1420TT variant. 188
The -1131 T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study 188
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease. 187
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 186
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 185
Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation 184
Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review 184
Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and “Insulin-Resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction 183
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 183
Vitamins and epigenetics 182
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 181
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 181
Hyperhomocysteinemia in relation to total and cardiovascular death after coronary bypass grafting. 179
Homozygosity for APOCIII variant at position 455 of insulin responsive element promoter region is associated with increased APOC-III levels and risk of coronary artery disease 178
Effects Of Female Sex Hormones And Contraceptive Pill On The Diagnostic Work-Up For Primary Aldosteronism 178
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 177
Antihypertensive efficacy of spironolactone: what about sex? 176
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 176
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 176
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 176
Aldosterone to renin ratio in a primary care setting: the Bussolengo study 175
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 175
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 175
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 174
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 173
Case Report: Microangiopathic Hemolytic Anemia With Normal ADAMTS13 Activity 173
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 173
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 171
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 171
Determinants of serum ferritin in the metabolic syndrome. 171
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 171
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 170
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 170
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 170
Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism 169
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 169
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 169
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in advanced coronary artery disease. 169
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 168
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 168
Genetic and environmental determinants of hyperhomocysteinemia in subjects with angiographically proven coronary artery disease 168
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 167
Interaction between smoking and PON2 Ser311 Cys polymorphism as a determinant of the risk of myocardial infarction 166
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 166
Impaired activity of 11--hydroxysteroid dehydrogenase type 2 in glucocorticoid treated and in hypertensive patients from primary and tertiary care. 164
ApoE epsilon 2/epsilon 3/epsilon 4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome 164
Reduced genomic DNA methylation in peripheral mononuclear cells as an index for the occurrence of cancer disease 164
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease 163
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. 163
The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers 163
Prevalence of body iron excess in the metabolic syndrome. 162
A late diagnosis of Primary Aldosteronism 162
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 162
Delation variant of ACE gene is associated with atherosclerotic renal stenosis not with coronary artery disease 160
Homocysteine and atheromatous renal artery stenosis 159
Genetic and eviromental determinants of hyperhomocysteinemia in subjects with corocary artery disease 159
Carriership of apolipoprotein CIII –455C gene variant strongly increases the coronary artery disease risk associated with the metabolic sindrome. 159
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 158
La diagnostica di laboratorio nella sindrome da apparente eccesso di mineralcorticoidi [The laboratory diagnosis of apparent mineralocorticoid excess (AME)] 157
Primary aldosteronism is a frequent cause of poor blood pressure control despite techically successful endovascular treatment of renal artery stenosis 156
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis. 156
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 155
Apolipoprotein CIII,metabolic syndrome,and risk of coronary artery disease. 154
CYSTATIN C VERSUS CREATININE IN RENOVASCULAR DISEASE. 153
Delation variant of ACE gene is associated wwith atherosclerotic renal artery stenosis not with coronary artery disease 153
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 153
Aldosterone to Renin Ratio (ARR) in Clinical use, with Reference to the Primary Care Setting: ARR to Whom, When, How, What for? 152
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 151
Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. 151
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 150
Totale 18.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.616
article - articoli 55.387
book - libri 0
conference - conferenze 31.770
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.459
Totale 177.232
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.098 0 300 15 117 64 41 15 60 54 38 112 282
2022/20232.922 197 315 250 504 295 659 23 206 352 17 66 38
2023/20241.601 62 101 122 137 170 354 46 116 21 57 230 185
2024/20253.452 187 228 130 599 130 121 211 106 506 226 312 696
2025/202611.170 721 561 1.042 1.844 2.958 773 974 503 806 627 122 239
2026/2027376 113 263 0 0 0 0 0 0 0 0 0 0
Totale 27.277